Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
100%
Malignant Neoplasm
73%
Galectin 3
56%
Colon Tumor
56%
Carcinogenesis
56%
Dysbiosis
56%
Mouse
56%
Colorectal Cancer
33%
Heart Infarction
22%
Fibrosis
18%
Disease
18%
Feces microflora
11%
Biological Marker
6%
Triacylglycerol
6%
Coronary Artery Disease
6%
C Reactive Protein
6%
Diabetes Mellitus
6%
Preclinical Study
5%
Cancer Growth
5%
Germfree Mouse
5%
C57BL 6 Mouse
5%
Azoxymethane
5%
Tumor Growth
5%
Dextran Sulfate
5%
Neoplasm
5%
Intestine Flora
5%
Heart Cancer
5%
Microbiome
5%
RNA 16S
5%
Keyphrases
Fibrotic Markers
56%
Galectin-3 (Gal-3)
56%
New Onset
42%
New-onset Heart Failure
35%
Cancer Onset
14%
Heart Failure
14%
Fibrosis
14%
Disease Entity
7%
Coronary Artery Disease
7%
Cancer-specific
7%
Estimated Glomerular Filtration Rate
7%
Body Mass Index
7%
Three-level
7%
Triglycerides
7%
Fibrosis Marker
7%
Cox Regression Analysis
7%
C-reactive Protein
7%
Individuals at Risk
7%
Leading Causes of Death
7%
Sex-stratified
7%
Healthy Participants
7%
Log-rank Test
7%
End-organ Disease
7%
Sex-specific
7%
Smoking Status
7%
Western World
7%
Hypertension
7%
Type 1 Diabetes Mellitus (T1DM)
7%
Azoxymethane/dextran Sodium Sulfate
7%
Medicine and Dentistry
Galectin 3
56%
Malignant Neoplasm
56%
Heart Failure
43%
Fibrosis
18%
Disease
12%
Proportional Hazards Model
6%
Log Rank Test
6%
Glomerular Filtration Rate
6%
C Reactive Protein
6%
Triacylglycerol
6%
Coronary Artery Disease
6%
Body Mass Index
6%
Diabetes Mellitus
6%
Biological Marker
6%